Share on StockTwits

Abbott Laboratories (NYSE:ABT) announced a quarterly dividend on Friday, February 21st, AnalystRatings.Net reports. Stockholders of record on Tuesday, April 15th will be paid a dividend of 0.22 per share on Thursday, May 15th. This represents a $0.88 annualized dividend and a dividend yield of 2.26%.

Several analysts have recently commented on the stock. Analysts at Jefferies Group cut their price target on shares of Abbott Laboratories to $46.00 in a research note on Wednesday, February 12th. They now have a “buy” rating on the stock. On a related note, analysts at Zacks reiterated a “neutral” rating on shares of Abbott Laboratories in a research note on Thursday, January 23rd. They now have a $40.00 price target on the stock. Finally, analysts at Leerink Swann raised their price target on shares of Abbott Laboratories from $37.00 to $40.00 in a research note on Thursday, January 23rd. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and eight have issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average price target of $39.42.

Abbott Laboratories (NYSE:ABT) traded up 0.55% on Friday, hitting $39.1652. The stock had a trading volume of 3,601,815 shares. Abbott Laboratories has a 52-week low of $32.70 and a 52-week high of $39.86. The stock has a 50-day moving average of $37.99 and a 200-day moving average of $36.48. The company has a market cap of $60.557 billion and a price-to-earnings ratio of 24.00.

Abbott Laboratories (NYSE:ABT) last announced its earnings results on Wednesday, January 22nd. The company reported $0.58 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.58. The company had revenue of $5.66 billion for the quarter, compared to the consensus estimate of $5.72 billion. During the same quarter last year, the company posted $1.51 earnings per share. Abbott Laboratories’s revenue was up .4% compared to the same quarter last year. On average, analysts predict that Abbott Laboratories will post $2.20 earnings per share for the current fiscal year.

In other Abbott Laboratories news, EVP John Landgraf sold 1,583 shares of the stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $39.10, for a total value of $61,895.30. Following the completion of the transaction, the executive vice president now directly owns 102,421 shares in the company, valued at approximately $4,004,661. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Abbott Laboratories (NYSE:ABT), is engaged in the discovery, development, manufacture, and sale of a portfolio of science-based health care products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.